Table 1.
Demographics | Pregabalin (n=55) |
Placebo (n=52) |
---|---|---|
Age | ||
Mean (years) | 27.25±5.45 | 27.19±6.02 |
Race * | ||
White | 20 (36.4%) | 21 (40.4%) |
Black | 4 (7.3%) | 3 (5.8%) |
Asian | 34 (61.8%) | 27 (51.9%) |
Native Hawaiian | 17 (30.9%) | 17 (32.7%) |
Hispanic | 10 (18.2%) | 7 (13.5%) |
Other | 4 (7.3%) | 3 (5.8%) |
Multiracial | 23 (41.8%) | 21 (40.4%) |
Education | ||
Some high school | 0 (0%) | 3 (5.8%) |
Graduated high school | 8 (14.5%) | 13 (25%) |
Some college | 29 (52.7%) | 24 (46.2%) |
Graduated college | 15 (27.3%) | 12 (23.1%) |
Post-college degree | 3 (5.5%) | 0 (0%) |
Mental Health | ||
Depression | 11 (20%) | 10 (19.2%) |
Anxiety | 7 (12.7%) | 9 (17.3%) |
Pregnancy history | ||
First pregnancy | 16 (29.1%) | 16 (30.8%) |
Prior surgical abortion | 22 (40%) | 18 (34.6%) |
Prior medical abortion | 6 (10.9%) | 7 (13.5%) |
Prior miscarriage | 13 (23.6%) | 11 (22.2%) |
Parous | 33 (60%) | 29 (55.8%) |
Prior vaginal delivery | 29 (52.7%) | 25 (48.1%) |
Prior cesarean section | 5 (9.1%) | 7 (13.5%) |
Gestational age | ||
Mean (days) | 53.51±8.16 | 55.15±6.90 |
Groups (days) | ||
41-49 | 19 (34.5%) | 14 (26.9%) |
50-56 | 14 (25.5%) | 19 (36.5%) |
57-63 | 15 (27.3%) | 12 (23.1%) |
64-70 | 7 (12.7%) | 7 (13.5%) |
Data are n (%) or mean ± standard deviation.
Participants could select more than one race.